“The eTRE (early time-restricted eating) intervention may therefore be an effective treatment for both obesity and hypertension,” the authors said.

“However, eTRE did not affect most fasting cardiometabolic risk factors in the main intention-to-treat analysis.”.

“Our data suggest that eTRE is feasible, as participants adhered six days per week on average, and most participants adhered at least five days per week,” the authors said.

“Future clinical trials will need to enroll much larger sample sizes — up to approximately 300 participants — to determine whether IF (intermittent fasting) affects body composition and cardiometabolic health,” the authors said.

“Future studies should investigate whether the timing and duration of the eating window affect these results, as well as determine who can adhere to eTRE vs.